Canntab Therapeutics Pink Sheet Forecast - 8 Period Moving Average

CTABF Stock  USD 0.0001  0.00  0.00%   
The 8 Period Moving Average forecasted value of Canntab Therapeutics Limited on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. Canntab Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Canntab Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
An 8-period moving average forecast model for Canntab Therapeutics is based on an artificially constructed time series of Canntab Therapeutics daily prices in which the value for a trading day is replaced by the mean of that value and the values for 8 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

Canntab Therapeutics 8 Period Moving Average Price Forecast For the 15th of December 2024

Given 90 days horizon, the 8 Period Moving Average forecasted value of Canntab Therapeutics Limited on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.
Please note that although there have been many attempts to predict Canntab Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Canntab Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Canntab Therapeutics Pink Sheet Forecast Pattern

Backtest Canntab TherapeuticsCanntab Therapeutics Price PredictionBuy or Sell Advice 

Canntab Therapeutics Forecasted Value

In the context of forecasting Canntab Therapeutics' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Canntab Therapeutics' downside and upside margins for the forecasting period are 0.0001 and 0.0001, respectively. We have considered Canntab Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.0001
0.0001
Downside
0.0001
Expected Value
0.0001
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 8 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Canntab Therapeutics pink sheet data series using in forecasting. Note that when a statistical model is used to represent Canntab Therapeutics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria11.9121
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0
MAPEMean absolute percentage error0.0
SAESum of the absolute errors0.0
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. Canntab Therapeutics Limited 8-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for Canntab Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Canntab Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Canntab Therapeutics. Your research has to be compared to or analyzed against Canntab Therapeutics' peers to derive any actionable benefits. When done correctly, Canntab Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Canntab Therapeutics.

Other Forecasting Options for Canntab Therapeutics

For every potential investor in Canntab, whether a beginner or expert, Canntab Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Canntab Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Canntab. Basic forecasting techniques help filter out the noise by identifying Canntab Therapeutics' price trends.

Canntab Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Canntab Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Canntab Therapeutics could also be used in its relative valuation, which is a method of valuing Canntab Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Canntab Therapeutics Technical and Predictive Analytics

The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Canntab Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Canntab Therapeutics' current price.

Canntab Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Canntab Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Canntab Therapeutics shares will generate the highest return on investment. By undertsting and applying Canntab Therapeutics pink sheet market strength indicators, traders can identify Canntab Therapeutics Limited entry and exit signals to maximize returns.

Currently Active Assets on Macroaxis

Other Information on Investing in Canntab Pink Sheet

Canntab Therapeutics financial ratios help investors to determine whether Canntab Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Canntab with respect to the benefits of owning Canntab Therapeutics security.